S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
NASDAQ:OMER

Omeros (OMER) News Today

$2.99
+0.05 (+1.70%)
(As of 09/25/2023 ET)
Compare
Today's Range
$2.84
$2.99
50-Day Range
$2.81
$5.69
52-Week Range
$1.74
$7.80
Volume
267,368 shs
Average Volume
681,944 shs
Market Capitalization
$187.94 million
P/E Ratio
4.67
Dividend Yield
N/A
Price Target
$8.00
SourceHeadline
MarketBeat logoContrasting Allarity Therapeutics (NASDAQ:ALLR) & Omeros (NASDAQ:OMER)
americanbankingnews.com - September 16 at 1:30 AM
marketbeat.com logoBarclays PLC Grows Stock Holdings in Omeros Co. (NASDAQ:OMER)
marketbeat.com - August 30 at 4:17 AM
msn.com logoOmeros: Where Medical Hopes Tangle With Fiscal Ropes
msn.com - August 24 at 7:01 PM
msn.com logoOmeros: Betting Big On Narsoplimab, We Are Still A Buyer
msn.com - August 23 at 9:41 AM
finance.yahoo.com logoInstitutions own 40% of Omeros Corporation (NASDAQ:OMER) shares but individual investors control 56% of the company
finance.yahoo.com - August 15 at 9:23 AM
msn.com logoOmeros GAAP EPS of -$0.70 misses by $0.13
msn.com - August 9 at 9:47 AM
finance.yahoo.com logoOmeros Corporation Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 9 at 9:47 AM
seekingalpha.com logoOmeros Q2 2023 Earnings Preview
seekingalpha.com - August 8 at 6:45 PM
marketbeat.com logoOmeros (NASDAQ:OMER) Upgraded by StockNews.com to "Hold"
marketbeat.com - August 4 at 9:15 PM
finance.yahoo.com logoOmeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023
finance.yahoo.com - August 4 at 6:30 PM
money.usnews.com logoOmeros Corporation
money.usnews.com - July 25 at 1:57 PM
marketbeat.com logoOmeros Co. Forecasted to Earn FY2024 Earnings of ($2.06) Per Share (NASDAQ:OMER)
marketbeat.com - July 14 at 7:22 AM
finance.yahoo.com logoMonoclonal Antibodies Industry Analysis 2023: 180+ Companies, 230+ Drugs, Therapeutics Assessment, Inactive Pipeline Products, Unmet Needs
finance.yahoo.com - June 26 at 7:51 AM
finance.yahoo.com logoGlobal Monoclonal Antibodies Market Landscape Assessment 2023: Developments, Trends, Competitors and Products
finance.yahoo.com - June 23 at 2:24 PM
finance.yahoo.com logoOmeros Corporation Announces Availability on Its Website of Materials Accompanying Presentations of OMS906 Data at the 2023 European Hematology Association Congress
finance.yahoo.com - June 12 at 7:43 PM
finance.yahoo.com logoWhy Shares of Omeros Dropped on Monday
finance.yahoo.com - June 12 at 7:43 PM
marketbeat.com logoOmeros Co. (NASDAQ:OMER) Holdings Lifted by Cambridge Investment Research Advisors Inc.
marketbeat.com - June 2 at 4:42 AM
seekingalpha.com logoOMER, TWST and RXTR are among after hour movers
seekingalpha.com - June 1 at 9:25 PM
finance.yahoo.com logoOmeros Corporation Announces Late-Breaking Presentation of OMS906 Data at the 2023 European Hematology Association (EHA) Congress
finance.yahoo.com - June 1 at 4:25 PM
msn.com logoUnusual Call Option Trade in Omeros (OMER) Worth $30.00K
msn.com - May 17 at 8:50 PM
msn.com logoOmeros: Q1 Earning Overview, Best Contrarian Biotech Play Of 2023
msn.com - May 16 at 8:04 PM
msn.com logoOmeros Q1 2023 Earnings Preview
msn.com - May 11 at 12:57 AM
msn.com logoEarnings Preview: Omeros
msn.com - May 11 at 12:57 AM
apnews.com logoOmeros: Q1 Earnings Snapshot
apnews.com - May 11 at 12:57 AM
msn.com logoOmeros: Q1 Earnings Insights
msn.com - May 11 at 12:57 AM
benzinga.com logoOmeros Stock (NASDAQ:OMER), Dividends
benzinga.com - May 10 at 7:57 PM
finance.yahoo.com logoOmeros Corporation Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 9 at 6:55 PM
marketbeat.com logoOmeros (OMER) Set to Announce Earnings on Tuesday
marketbeat.com - May 5 at 9:46 AM
finance.yahoo.com logoOmeros Corporation to Announce First Quarter Financial Results on May 9, 2023
finance.yahoo.com - May 4 at 7:03 PM
finance.yahoo.com logoOmeros Corporation Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria
finance.yahoo.com - April 25 at 10:53 AM
bizjournals.com logoOmeros lands $6.7M grant to test treatment for cocaine addiction
bizjournals.com - April 12 at 10:00 AM
finance.yahoo.com logoOmeros Corporation Awarded $6.69 Million Grant from the National Institute on Drug Abuse for its OMS527 Addiction Program
finance.yahoo.com - April 10 at 9:47 AM
finance.yahoo.com logoQ4 2022 Omeros Corp Earnings Call
finance.yahoo.com - March 14 at 4:36 PM
finance.yahoo.com logoOmeros Corporation (NASDAQ:OMER) Q4 2022 Earnings Call Transcript
finance.yahoo.com - March 14 at 4:36 PM
seekingalpha.com logoOmeros stock climbs amid Q4 Omidria royalty revenue; eyes FDA refiling for narsoplimab
seekingalpha.com - March 14 at 12:21 PM
finance.yahoo.com logoOmeros Corporation Reports Fourth Quarter and Year-End 2022 Financial Results
finance.yahoo.com - March 13 at 7:03 PM
finance.yahoo.com logoOmeros Corporation Confirms Absence of Financial Exposure to Silicon Valley Bank
finance.yahoo.com - March 10 at 6:11 PM
finance.yahoo.com logoOmeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023
finance.yahoo.com - March 7 at 9:18 AM
finance.yahoo.com logoWhy Omeros Stock Bolted Higher This Week
finance.yahoo.com - February 9 at 6:11 PM
finance.yahoo.com logoWhy Omeros Corporation Stock Is Skyrocketing Today
finance.yahoo.com - February 6 at 4:35 PM
finance.yahoo.com logoOmeros Corporation Receives $200 Million Milestone Payment from Rayner Surgical
finance.yahoo.com - February 6 at 10:28 AM
bizjournals.com logoParse Biosciences moves into new South Lake Union space
bizjournals.com - January 23 at 5:43 AM
marketwatch.com logoPlasminogen Market 2023 : Recent Developments, Industry Trends and Investigation Growth Rate, and Forecast to 2028
marketwatch.com - January 15 at 5:24 AM
marketwatch.com logoPNH and aHUS Market Massive Growth Strikes Due To Technological Innovation During 2023-2028
marketwatch.com - January 12 at 8:42 AM
marketwatch.com logoComplement Drug Market 2023 Statistics, Share Price, Growth Prospects, Industry Trends till 2029
marketwatch.com - January 11 at 10:45 PM
marketwatch.com logoComplement Drug for Kidney Disease Market Global and Regional Analysis and Forecast 2028
marketwatch.com - January 5 at 8:44 AM
seekingalpha.com logoOmeros' Deafening Silence
seekingalpha.com - December 27 at 1:14 AM
marketbeat.com logoOmeros Target of Unusually Large Options Trading (NASDAQ:OMER)
marketbeat.com - December 23 at 11:57 AM
insidermonkey.com logo5 Cheapest Stocks With Biggest Upside
insidermonkey.com - December 19 at 12:53 PM
marketwatch.com logoPlasminogen Market 2023 : Trends, Industry Structure, Development, Demographics, Developing Factors By 2028
marketwatch.com - December 13 at 7:45 AM
Get Omeros News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter.



OMER Media Mentions By Week

OMER Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OMER
News Sentiment

0.00

0.50

Average
Medical
News Sentiment

OMER News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OMER Articles
This Week

0

1

OMER Articles
Average Week

Get Omeros News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:OMER) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -